Corxel US Advances Portfolio of Oral Drug Candidates
Amanat says Corxel US is advancing oral drug candidates designed to address limitations of existing injectable and oral obesity therapies.
Amanat says Corxel US is advancing oral drug candidates designed to address limitations of existing injectable and oral obesity therapies.